$235.59 0.9%
ALNY Stock Price vs. AI Score
Data gathered: July 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.


Alnylam Pharmaceuticals
Price $235.59
Target Price Sign up
Volume 529,760
Market Cap $30.1B
Year Range $143.31 - $261.02
Dividend Yield 0%
Earnings Date August 1 '24
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24459M265M194M-66M-30M-0.520
Q4 '23408M270M138M-138M-103M-1.100
Q3 '23720M279M441M148M182M1.150
Q2 '23289M290M-1.3M-276M-244M-2.210
Q1 '23290M225M65M-174M-143M-1.400

Insider Transactions View All

Greenstreet Yvonne filed to sell 73,441 shares at $261.
July 12 '24
Fitzgerald Kevin Joseph filed to sell 15,325 shares at $224.2.
June 26 '24
Fitzgerald Kevin Joseph filed to sell 15,312 shares at $225.6.
June 26 '24
Fitzgerald Kevin Joseph filed to sell 15,286 shares at $226.8.
June 26 '24
Fitzgerald Kevin Joseph filed to sell 15,334 shares at $221.7.
June 26 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Feb 15, 24 Buy $1K - $15K
Joshua Gottheimer
Democrat
Feb 15, 24 Sell $1K - $15K
Joshua Gottheimer
Democrat
Jan 7, 24 Sell $1K - $15K

What is the Market Cap of Alnylam Pharmaceuticals?

The Market Cap of Alnylam Pharmaceuticals is $30.1B.

When does Alnylam Pharmaceuticals report earnings?

Alnylam Pharmaceuticals will report its next earnings on August 1 '24.

What is the current stock price of Alnylam Pharmaceuticals?

Currently, the price of one share of Alnylam Pharmaceuticals stock is $235.59.

How can I analyze the ALNY stock price chart for investment decisions?

The ALNY stock price chart above provides a comprehensive visual representation of Alnylam Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Alnylam Pharmaceuticals shares. Our platform offers an up-to-date ALNY stock price chart, along with technical data analysis and alternative data insights.

Does ALNY offer dividends to its shareholders?

As of our latest update, Alnylam Pharmaceuticals (ALNY) does not offer dividends to its shareholders. Investors interested in Alnylam Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Alnylam Pharmaceuticals?

Some of the similar stocks of Alnylam Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.